1. Codeine and clinical impairment in samples in which morphine is not detected

   • Liliana Bachs
   • Svetlana Skurtveit
   • Jørg Mørland

   Pharmacodynamics 01 March 2003 Pages: 785 - 789

   

2. Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypes

   • Craig R. Lee
   • John A. Pieper
   • Joyce A. Goldstein

   Pharmacokinetics and Disposition 26 February 2003 Pages: 791 - 794

   

3. Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects

   • Robert Hermann
   • Norbert G. Knebel
   • Mathias Locher

   Pharmacokinetics and Disposition 28 February 2003 Pages: 795 - 802

   

4. Diosmin pretreatment affects bioavailability of metronidazole

   • K. Rajnarayana
   • Mada S. Reddy
   • Devarakonda R. Krishna

   Pharmacokinetics and Disposition 01 March 2003 Pages: 803 - 807

   

5. Digoxin pharmacokinetics and MDR1 genetic polymorphisms

   • Céline Verstuyft
   • Mathias Schwab
   • Laurent Becquemont

   Pharmacokinetics and Disposition 01 March 2003 Pages: 809 - 812

   

6. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC_0–12 monitoring in cardiac transplant recipients over the first year post-transplantation

   • C. Monchaud
   • A. Rousseau
   • P. Marquet

   Pharmacokinetics and Disposition 06 March 2003 Pages: 813 - 820

   

7. Awareness of the side effects of possessed medications in a community setting

   • Panagiotis N. Papanikolaou
   • John P. A. Ioannidis

   Pharmacokinetics and Disposition 07 March 2003 Pages: 821 - 827

8. Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles

   • Yutaro Suzuki
   • Toshiki Shioiri
   • Toshiyuki Someya

   Pharmacokinetics and Disposition 15 March 2003 Pages: 829 - 833

   

9. Under-prescribing of cardiovascular therapies for diabetes in primary care

   • K. E. Bennett
   • D. Williams
   • J. Feely

   Pharmacoepidemiology and Prescription 26 February 2003 Pages: 835 - 841

10. Problems in collecting comparable national drug use data in Europe: the example of antibacterials

    • Marit Rønning
    • Hege Salvesen Blix
    • Robert Vander Stichele

    Pharmacoepidemiology and Prescription 18 March 2003 Pages: 843 - 849

    

11. Trends in prescribing antihypertensive drugs in the Gruppo Italiano di Farmacovigilanza nell'Anziano 1988–1997

    • Raffaele Antonelli Incalzi
    • Andrea Corsonello
    • Pierugo Carbonin

    Letter to the Editors 08 March 2003 Pages: 851 - 852